Lungs sarcoidosis

Due to its biological and medicinal features, Aviptadil promises great upside potential as a therapeutic option in additional different lung diseases, such as lung sarcoidosis, and beyond. 

Gifre L, Ruiz-Esquide V, Xaubet A, G6mez-Puerta JA, Herndndez MV, Sanmarti R. Lung sarcoidosis induced by TNF antagonists in rheumatoid arthritis a case presentation and a literature review. Arch Bronconeumol 2011 47(4) 208-12. 

Generally, a CA 15-3 cutoff of 25 U/ml is used to detect stage I breast cancer. In higher stages, the sensitivity is reported to be much better, which makes it a good test of tumor burden. CA 15-3 is reported to be elevated in other disease conditions such as liver disease (particularly chronic hepatitis, cirrhosis, and carcinoma), some inflammatory conditions (sarcoidosis, tuberculosis, systemic erythematosus), and other carcinoma (lung and ovary). For this reason, positive CA 15-3 results should be interpreted with caution (20,21). 

Suggested Alternatives for Differential Diagnosis Blastomycosis, coccidioidomycosis, aspergillosis, pneumonia, respiratory distress syndrome, mediastinal cysts, mycoplasma infections, Pancoast syndrome, sarcoidosis, tuberculosis, lung abscess, lung cancer, lymphoma. 

Sarcoidosis and Other Granulomatous Diseases of the Lung, edited by B. L. Fanburg... 

Sarcoidosis is a primary multisystemic, granulomatous disease of (still) unknown aetiology with enhanced immunity at the site of manifestation. The lungs and the intrathoracic lymph nodes are nearly always affected. In many cases, the extrathoracic organs are involved as well. Sarcoidosis is characterized by the presence of epithelioid cell granulomas, which do not show caseous changes. 

Carrabino N, Luisetti M. Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. Sarcoidosis Vase Diffuse Lung Dis 2000 17(3) 288-91. 

Baughman RP, Lower EE. Leflunomide for chronic sarcoidosis. Sarcoidosis Vase Diffuse Lung Dis 2004 21(1) 43-8. 

Hance, A.J., Douches, S., Winchester, R.J., Ferrans, J. and Crystal, R.J. (1985). Characterisation of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis. J. Immunol. 134, 284-292. 

Homolka, J. and Muller Q.M. (1993). Increased Interleukin 6 production by bronchoalveolar lavage in patients with active sarcoidosis. Lung 171, 173-183. 

Interstitial lung diseases Idiopathic pulmonary fibrosis Sarcoidosis... 

Finally, WHO group V includes diagnoses not fitting into any of the above categories, such as sarcoidosis, pulmonary histiocytosis, extrinsic compression of pulmonary artery, etc. Sarcoidosis may involve chronic lung disease, an active vasculitis, extrinsic compression, or cardiac disease. 

Source Reprinted from Azuma et al. [89] with permission from the Sarcoidosis Vasculitis and Diffuse Lung Disease. 

Azuma, A., Keicho, N., Furukawa, H., Yabe, T., and Kudoh, S. (2001). Prolonged survival of bare lymphocyte syndrome Type I patient with diffuse panbronchiolitis treated with erythromycin. Sarcoidosis Vasculitis and Dijfuse Lung Disease 18, 312-313. 

Increased production of IL-2 has been observed in other clinical conditions. For example, lung cells (presumably containing X lymphocytes) from patients with sarcoidosis and high-intensity alveolitis spontaneously release IL-2.78... 

---